Literature DB >> 9366262

Adenylyl cyclase type II is stimulated by PKC via C-terminal phosphorylation.

G F Böl1, A Hülster, T Pfeuffer.   

Abstract

Adenylyl cyclases of the type II family differ from other subforms in that they are conditionally stimulated via alpha(s)/betagamma subunits and regulated by PKC mediated phosphorylation. AC II, stably expressed in HEK 239 cells, was incubated with the PKC activator tetradecanoylphorbol acetate (TPA). Using cells metabolically labeled with [32P]phosphate, TPA caused concerted stimulation of basal and forskolin activated adenylyl cyclase together with incorporation of [32P]phosphate into AC II protein. Enhanced phosphorylation was also indicated by a monoclonal anti-phosphothreonine antibody. Assignment of TPA-induced [32P]phosphate-incorporation to specific sites was achieved by a combination of chemical and immunochemical methods. Three out of five [32P]labeled peptides that were generated by fragmentation with N-chlorosuccinimide were also recognized by the monoclonal antibody BBC-4 [S. Mollner, T. Pfeuffer, Eur. J. Biochem. 171 (1988) 265-271] directed against an epitope 8 kDa from the extreme C-terminus. These findings suggested Ser-871 (consensus sequence ARSLK) and Thr-1057 (CTCR) as acceptor candidates of phorbolester induced phosphoryl transfer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366262     DOI: 10.1016/s0167-4889(97)00073-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Authors:  Rennolds S Ostrom; Amy S Bogard; Robert Gros; Ross D Feldman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-20       Impact factor: 3.000

2.  FasL expression in activated T lymphocytes involves HuR-mediated stabilization.

Authors:  Gillian L Drury; Sergio Di Marco; Virginie Dormoy-Raclet; Julie Desbarats; Imed-Eddine Gallouzi
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

Review 3.  Regulation by Ca2+-signaling pathways of adenylyl cyclases.

Authors:  Michelle L Halls; Dermot M F Cooper
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Cross-Talk Between the Adenylyl Cyclase/cAMP Pathway and Ca2+ Homeostasis.

Authors:  Jose Sanchez-Collado; Jose J Lopez; Isaac Jardin; Gines M Salido; Juan A Rosado
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 5.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

6.  Molecular mechanisms underlying a cellular analog of operant reward learning.

Authors:  Fred D Lorenzetti; Douglas A Baxter; John H Byrne
Journal:  Neuron       Date:  2008-09-11       Impact factor: 17.173

7.  Non-raft adenylyl cyclase 2 defines a cAMP signaling compartment that selectively regulates IL-6 expression in airway smooth muscle cells: differential regulation of gene expression by AC isoforms.

Authors:  Amy S Bogard; Anna V Birg; Rennolds S Ostrom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-12-22       Impact factor: 3.000

Review 8.  Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.

Authors:  Rachna Sadana; Carmen W Dessauer
Journal:  Neurosignals       Date:  2008-10-24

9.  PKCβII acts downstream of chemoattractant receptors and mTORC2 to regulate cAMP production and myosin II activity in neutrophils.

Authors:  Lunhua Liu; Derek Gritz; Carole A Parent
Journal:  Mol Biol Cell       Date:  2014-03-05       Impact factor: 4.138

10.  Muscarinic receptors stimulate AC2 by novel phosphorylation sites, whereas Gβγ subunits exert opposing effects depending on the G-protein source.

Authors:  Jia X Shen; Sebastian Wachten; Michelle L Halls; Katy L Everett; Dermot M F Cooper
Journal:  Biochem J       Date:  2012-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.